Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005;7(3):126-8.
doi: 10.1186/ar1755. Epub 2005 Apr 18.

Cold hands--strained heart? Advances in the management of Raynaud's phenomenon and pulmonary hypertension

Affiliations
Review

Cold hands--strained heart? Advances in the management of Raynaud's phenomenon and pulmonary hypertension

Frances C Hall. Arthritis Res Ther. 2005.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Dysfunction of cellular components of the arterial wall and of inflammatory and haemostatic systems are interrelated.

References

    1. Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, Black CM, Coghlan JG. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis. 2003;62:1088–1093. doi: 10.1136/ard.62.11.1088. - DOI - PMC - PubMed
    1. Kahaleh MB. Raynaud phenomenon and the vascular disease in scleroderma. Curr Opin Rheumatol. 2004;16:718–722. doi: 10.1097/01.bor.0000138677.88694.a4. - DOI - PubMed
    1. Varga J. Pulmonary hypertension in systemic sclerosis: bete noire no more? Curr Opin Rheumatol. 2002;14:671–680. doi: 10.1097/00002281-200211000-00007. - DOI - PubMed
    1. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF, Rabinovitch M. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43:13S–24S. doi: 10.1016/j.jacc.2004.02.029. - DOI - PubMed
    1. Jeffery TK, Wanstall JC. Pulmonary vascular remodelling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol Ther. 2001;92:1–20. doi: 10.1016/S0163-7258(01)00157-7. - DOI - PubMed

Publication types